RNA containing modified nucleosides and methods of use thereof
AssigneeThe Trustees of the University of Pennsylvania
InventorsKatalin Kariko, Drew Weissman
Life of this patent
Estimating the term…
Abstract
This invention provides RNA, oligoribonucleotide, and polyribonucleotide molecules comprising pseudouridine or a modified nucleoside, gene therapy vectors comprising same, methods of synthesizing same, and methods for gene replacement, gene therapy, gene transcription silencing, and the delivery of therapeutic proteins to tissue in vivo, comprising the molecules. The present invention also provides methods of reducing the immunogenicity of RNA, oligoribonucleotide, and polyribonucleotide molecules.
Claims22
A method for inducing a mammalian cell to produce a protein of interest, the method comprising:
- contacting said mammalian cell with an in vitro-synthesized modified RNA encoding the protein of interest, wherein the in vitro-synthesized modified RNA encoding the protein of interest is translated by the cell, and
- wherein said in vitro-synthesized modified-RNA comprises the modified nucleoside 5-methylcytidine (m5C).
Dependencies are inferred from the claim text.